AI assistant
DEXCOM INC — Director's Dealing 2020
Mar 10, 2020
30198_dirs_2020-03-10_0427ca6b-9596-43ef-9dc4-f49064379c51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-08
Reporting Person: Murphy Patrick Michael (*)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-08 | Common Stock | A | 8811 | $0.001 | Acquired | 35258 | Direct |
| 2020-03-09 | Common Stock | S | 500 | $261.0 | Disposed | 34758 | Direct |
Footnotes
F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
F3: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.